Sarepta Therapeutics | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Acadia Pharmaceuticals 0 4.12M 2024-09
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Daiichi Sankyo 11.62B 11.42B 2024-09
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 260M 12M 2025-03
Incyte USD 419K 355K 2024-12
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 213M 151M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Tectonic Therapeutic USD 22K 3K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Sarepta Therapeutics Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.